Skip to main content

February 2013 Vol 6, No 1, Special Issue

Rivaroxaban More Cost-Effective than Warfarin for Recurrent VTE Prevention
Caroline Helwick
Read More
Costs of Second-Line Metastatic Colorectal Cancer Treatments Compared
Caroline Helwick
Read More
Combined Chemoradiation Cost-Effective in Younger Patients with Primary CNS Lymphoma
Wayne Kuznar
Read More
Rasburicase Cost-Effective for Tumor Lysis Syndrome
Caroline Helwick
Read More
Internet-Based Tool Helps Guide Treatment Decisions in Patients with CML
Read More
Faster Rituximab Infusion Lowers Cost
Caroline Helwick
Read More
Selective JAK Inhibitor Cost-Effective Option for Patients with Myelofibrosis
Wayne Kuznar
Read More
Leukemia, Oncology
New Targeted Agent Shows Significant Success in Treating Refractory Form of AML
Wayne Kuznar
Read More
Hematologic Drug Pipeline Is Bustling
Caroline Helwick
Read More
Azacitidine Reduces Transfusions and Costs for Patients with High-Risk MDS
Caroline Helwick
Read More
Page 3 of 3
Results 21 - 30 of 30